AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 276: H608-H613, 1999;
0363-6135/99 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, W.
Right arrow Articles by Toyama, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, W.
Right arrow Articles by Toyama, J.
Vol. 276, Issue 2, H608-H613, February 1999

beta -Adrenergic modulation of L-type Ca2+-channel currents in early-stage embryonic mouse heart

Weiran Liu, Kenji Yasui, Akiko Arai, Kaichiro Kamiya, Jianhua Cheng, Itsuo Kodama, and Junji Toyama

Department of Circulation, Division of Regulation of Organ Function, Research Institute of Environmental Medicine, Nagoya University, Chikusa-ku, Nagoya 464-8601, Japan


    ABSTRACT
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References

Little information is available concerning the modulation of cardiac function by beta -adrenergic agonists in early-stage embryonic mammalian heart. We have examined the effects of isoproterenol (Iso) on the spontaneous beating rate and action potential (AP) configuration in embryonic mouse hearts at 9.5 days postcoitum (dpc), just 1 day after they started to beat. Iso (3 µM) increased the spontaneous beating rate in whole hearts, dissected ventricles, and isolated ventricular myocytes. In ventricular myocytes, Iso also increased the slope of the pacemaker potential and the action potential duration but decreased the maximum upstroke velocity. In whole cell voltage-clamp experiments, the Ca2+-channel currents were measured as Ba2+ currents (IBa). In 9.5-dpc myocytes, IBa was enhanced significantly from -4.7 ± 0.9 to -6.7 ± 1.2 pA/pF (by 52.4 ± 14.8%, n = 10) after the application of Iso. Propranolol (3 µM) reversed the effect of Iso. Forskolin (For, 10 µM) produced an increase in IBa by 95.5 ± 18.8% (n = 8). In ventricular myocytes at a late embryonic stage (18 dpc), 3 µM Iso caused an appreciably greater increase in IBa from -6.2 ± 0.5 to -14.5 ± 2.2 pA/pF (by 137.8 ± 33.0%, n = 8), whereas the increase in IBa by 10 µM For (by 120.0 ± 23.0%, n = 7) was comparable to that observed in the early stage (9.5 dpc). These results indicate that the L-type Ca2+-channel currents are modulated by beta -adrenergic receptors in the embryonic mouse heart as early as 9.5 dpc, probably via a cAMP-dependent pathway.

calcium ion channels; beta -adrenergic receptor; isoproterenol


    INTRODUCTION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References

IT IS WELL KNOWN that the beta -adrenergic system plays an important role in the regulation of cardiac excitation and contraction in mature mammals. The modulation of L-type Ca2+-channel currents in cardiomyocytes by beta -adrenergic receptors is the main process in the regulation of heart rate and excitation-contraction coupling. Although it is well established that beta -adrenergic agonists, by activating the Gs protein, stimulate cardiac Ca2+-channel currents via dual pathways, cAMP dependent and cAMP independent (24, 25), the beta -adrenergic modulation of Ca2+ channels in the embryonic heart is still ambiguous.

There is a considerable discrepancy in the literature as to the role of beta -adrenergic receptors in embryonic hearts at an early stage (within a couple of days after the initiation of beating). An et al. (1) reported that in the embryonic mouse heart, L-type Ca2+ channels are responsive to isoproterenol (Iso) in late-stage [17-20 days postcoitum (dpc)] cardiomyocytes but not in early-stage (11-13 dpc) cardiomyocytes. In rat cardiomyocytes, Iso has little effect on Ca2+-channel currents at fetal days 15 and 18 but has a marked stimulatory effect from fetal day 20 (14). However, biochemical studies proved the expression of beta -adrenergic receptors in 13-day-old fetal mouse heart or 12-day-old fetal rat heart (4, 5, 22). On the other hand, Robkin et al. (18, 19) reported that the chronotropic beta -adrenergic response of the rat heart appears at fetal day 10.5 or 11 in the explanted whole embryo, concomitant with the onset of heart beating (a rat embryo at day 11 of gestation corresponds to a mouse embryo at day 10 in terms of the stage of development). Similarly, Hall (8) found chronotropic beta -adrenergic response of isolated embryonic rat hearts at 10.5-13.5 dpc.

To clarify the functional role of beta -adrenergic receptors in the early-stage embryonic mouse heart, we examined the effect of Iso on the heart beating rate and electrophysiological properties of ventricular myocytes (action potential configuration and L-type Ca2+-channel currents) at 9.5 dpc. For comparison, we also examined the effect of Iso on L-type Ca2+-channel currents in 18-dpc ventricular myocytes. Our results indicate that activation of beta -adrenergic receptors does modulate heart beating and L-type Ca2+ channels in the 9.5-dpc embryonic mouse heart, although the modulatory potency is appreciably less than in the 18-dpc embryonic heart.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References

Dissection of 9.5-dpc mouse embryos and ventricles. Pregnant (9.5 dpc) mice were killed by cervical dislocation, the uteri were isolated, and the whole embryos were exposed. Ventricles were cut from the exposed embryos. During the dissection procedures, the tissues were kept in Hanks' balanced salt solution (GIBCO).

Isolation of 9.5-dpc cardiomyocytes. The dissected ventricles were incubated in Ca2+-free saline with 0.3 mg/ml collagenase type II (Worthington Biochemical) containing (in mM) 116 NaCl, 20 HEPES, 1.0 NaH2PO4, 5.5 glucose, 5.0 KCl, and 0.8 MgSO4 (pH 7.35) for 20 min at 37°C and then rinsed with the same buffer solution without enzyme. The ventricles were mechanically dissociated by trituration. The cell suspensions were centrifuged at 1,000 rpm for 5 min, and the isolated cells were plated on collagen-coated glass coverslips and incubated in Dulbecco's modified Eagle medium (GIBCO) with 10% fetal bovine serum (GIBCO) and 10 µg/ml gentamicin at 37°C in a humidified CO2 incubator.

Isolation of 18-dpc cardiomyocytes. Ventricles were dissected from 18-dpc embryonic hearts and cut into pieces. The ventricular pieces were incubated in Dulbecco's phosphate-buffered saline containing 0.16 mg/ml collagenase (Yakult) with stirring at 37°C for 12 min, and cell suspension was collected; this was repeated four times. The collected suspension was centrifuged at 1,000 rpm for 5 min, and the isolated cells were cultured in the same way as 9.5-dpc cardiomyocytes.

Observation of heart beating. Embryos or ventricles (9.5 dpc) were transferred to a chamber perfused with normal Tyrode solution containing (in mM) 143 NaCl, 5.4 KCl, 1.8 CaCl2, 0.5 MgCl2, 5.5 glucose, and 5 HEPES (pH 7.4) maintained at 37°C. The heart rate was measured by the naked eye under an inverted microscope (Nikon).

Action potential recording. Action potentials (AP) were recorded from spontaneously beating myocytes, cultured for ~20 h, in a normal Tyrode solution. Pipettes (15-20 MOmega ) filled with an internal solution containing (in mM) 60 KOH, 80 KCl, 40 aspartate, 5 HEPES, 10 EGTA, 5 MgATP, 5 Na2-phosphocreatine, and 0.65 CaCl2 (pH 7.2) were sealed to the myocytes, and whole cell recording was initiated by suction with negative pressure. Electrical signals were fed into an Axopatch-1D (Axon Instruments), filtered at 2 kHz, and digitized at a sampling rate of 5 kHz.

Measurement of Ca2+-channel currents. Whole cell voltage-clamp recordings were performed from cardiac myocytes 20-28 h after plating. To isolate Ca2+-channel currents, the cells were perfused with a Na+- and K+-free solution containing (in mM) 2 BaCl2, 50 tetraethylammonium chloride, 100 Tris · Cl, 0.5 MgCl2, 3 4-aminopyridine, 5 HEPES, and 5.5 glucose (pH 7.4). Pipettes were pulled to resistances of 3.5-5.0 MOmega when filled with an internal solution containing (in mM) 80 CsCl, 60 CsOH, 40 aspartate, 5 HEPES, 10 EGTA, 5 MgATP, 5 Na2-phosphocreatine, and 0.65 CaCl2 (pH 7.2). Data were recorded with an Axopatch-1D (Axon Instruments), filtered at 2 kHz, digitized at 5 kHz, and stored on a microcomputer disk for subsequent off-line analysis. Experiments were performed at 33°C.

Chemicals. l-Isoproterenol, forskolin, and dl-propranolol were purchased from Sigma (St. Louis, MO).

Data analysis. Data were analyzed using the pCLAMP program (Axon Instruments). Current density was calculated using the measured membrane capacitance. The cell capacitance was determined by applying a ramp voltage pulse of ±0.5 V/s at a potential ranging between -50 mV and +70 mV. Data are expressed as means ± SE. The mean percentage of change was the average value of individual percentage. Statistical analysis was performed using Student's t-test, and values of P < 0.05 were considered to indicate a significant difference.


    RESULTS
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References

Effect of Iso on beating rates of 9.5-dpc whole hearts, ventricles, and ventricular myocytes. Table 1 compares the effects of Iso on beating rates of the whole hearts in vivo and those of the dissected ventricles and firing rates of AP recorded from isolated ventricular myocytes. There was no significant difference in the control beating rates between whole hearts and dissected ventricles. The spontaneous firing rate of isolated ventricular myocytes was slightly higher (by 13-15%) than the beating rates of whole hearts and of dissected ventricles. The increase in beating rate after Iso (3 µM) application in the whole hearts (by 17.0 ± 4.9%, n = 8) was similar to that in the dissected ventricles (by 16.5 ± 6.5%, n = 10). The corresponding value in ventricular myocytes (29.4 ± 3.8%, n = 8) was slightly larger than those in the whole hearts and dissected ventricles.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Effect of isoproterenol on whole hearts, dissected ventricles, and isolated ventricular myocytes

Effects of Iso on AP in ventricular myocytes. Figure 1 shows examples of AP before, during, and after the application of Iso (3 µM). AP fired spontaneously (101/min), with a slow diastolic depolarization. The maximal upstroke velocity (Vmax) under the control condition amounted to 70.4 V/s (Fig. 1A). During the application of Iso (3 µM), the AP firing rate increased to 138/min (Fig. 1B). This positive chronotropic effect was associated with an increase in the slope of slow diastolic depolarization and a prolongation of AP duration. The AP duration measured at -50 mV (APD-50) was prolonged by 30 ms. However, Vmax was decreased to 56.2 V/s. These AP changes partially recovered after the withdrawal of Iso (Fig. 1C).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of isoproterenol (Iso, 3 µM) on spontaneous action potentials in 9.5-day postcoitum (dpc) embryonic mouse ventricular myocyte. Representative action potentials (AP) were recorded in current-clamp mode. A, B, and C show AP before, during, and after application of Iso, respectively. Iso reversibly increased AP frequency, slope of slow diastolic potential (pacemaker potential), and prolonged AP duration. Horizontal lines indicate 0 mV potential.

Table 2 summarizes the effects of Iso on AP parameters. Neither maximum diastolic potential (MDP) nor AP amplitude (APA) was affected by Iso. However, Vmax was reduced by 13.9 ± 4.2% (P < 0.05, n = 8); the slope of the pacemaker potential and APD-50 were significantly increased by 57.6 ± 16.2% (P < 0.01, n = 8) and 17.9 ± 6.5% (P < 0.01, n = 8), respectively.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Action potential parameters in absence and presence of Iso

Effects of Iso and forskolin on L-type Ca2+-channel currents in ventricular myocytes. Whole cell voltage-clamp recordings were performed on dissociated ventricular myocytes at 9.5 dpc to examine the effect of Iso on L-type Ca2+-channel currents. To minimize rundown of Ca2+-channel currents and to obtain higher conductance, Ba2+ was used as a charge carrier of Ca2+-channel currents instead of Ca2+. The inward currents, evoked by 200-ms depolarizing pulses from a holding potential of -50 mV to 0 mV, were identified as an L-type Ca2+-channel current (IBa) because of their complete blockade by 1 µM nisoldipine (data not shown). Figure 2, A and B, shows an example: IBa was augmented by 28.6% after Iso (3 µM) application and recovered to control level after the addition of its antagonist, propranolol (3 µM).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of Iso and forskolin (For) on Ca2+-channel currents measured with Ba2+ as charge carrier (IBa) in 9.5-dpc embryonic mouse ventricular myocytes. A: peak IBa amplitude is plotted against time. Iso (3 µM) increased IBa, and propranolol (Pro, 3 µM) reversed Iso effect. IBa was elicited by a 200-ms voltage step to 0 mV from a holding potential of -50 mV. B: selected current traces are illustrated at points denoted on time course in A; a and b were recorded in absence and presence of Iso, respectively, and c in presence of Iso and Pro (3 µM). C: typical current traces showing effect of For (10 µM) on IBa in 9.5-dpc embryonic mouse ventricular myocyte. Pulse protocol is same as shown in B. Control and Forskolin, IBa recorded in absence and presence of 10 µM For, respectively.

Figure 3 shows the average current-voltage (I-V) relationship of the peak IBa density in the absence and the presence of Iso (3 µM). IBa was elicited by depolarizing pulses from a holding potential of -50 mV in 10-mV increments. Iso increased the maximum value of peak IBa (obtained at 0-mV test pulse) from -4.7 ± 0.9 to -6.7 ± 1.2 pA/pF (P < 0.01, n = 10) without a discernible shift of the voltage dependence of IBa.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of Iso on current-voltage (I-V) relationship of IBa in 9.5-dpc embryonic mouse ventricular myocytes. Peak I-V curve was obtained before (open circle ) and during (bullet ) application of Iso (3 µM). IBa was expressed as current density (pA/pF) calculated using membrane capacitance. Data points plotted are means ± SE (n = 10). Threshold was about -30 mV, and maximal activation of IBa occurred at 0 mV.

To investigate possible mechanisms underlying the response to Iso, we studied the effect of forskolin (For), a direct adenylate cyclase (AC) activator. For (10 µM) increased IBa by 95.5 ± 18.8% (n = 8). Representative current traces are shown in Fig. 2C.

Furthermore, to compare the developmental changes in responses to Iso and For, we also investigated the effects of Iso and For on IBa in late-stage (18 dpc) ventricular myocytes. Summarized whole cell voltage-clamp data are shown in Table 3. In 18-dpc myocytes, 3 µM Iso caused an appreciably greater increase in IBa (by 37.8 ± 33.0%, n = 8) than in 9.5-dpc myocytes (by 52.4 ± 14.8%, n = 10, P < 0.05). In contrast, the increase in IBa by 10 µM For at 18 dpc (by 120.0 ± 23.0%, n = 7) was comparable to that observed at 9.5 dpc (P > 0.05).

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Effects of Iso and For on IBa in mouse embryonic cardiomyocytes


    DISCUSSION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References

Initiation of heartbeat and Iso. During mouse embryogenesis, the primitive heart normally begins to contract irregularly at 8.5 dpc, whereas at 9 dpc of development the primitive atria and ventricles beat regularly and powerfully (10). In this study, an Iso-induced increase in the heart beating rate was observed at 9.5 dpc.

Studies on initiation of heart beating of embryos have been carried out extensively in chick embryos, but there are few reports regarding mammals. Hall (8) first reported that a stable heartbeat (140 beats/min) appeared in 10.5-dpc rat embryos and that the beating rate increased by 21% after exposure to epinephrine (27.3 µM). Similarly, Robkin et al. (19) observed an increase (by 13%) in the heart rate of 10.5-dpc rat embryos after Iso (1.6 µM) application. To our knowledge, we are the first to demonstrate that the heartbeat can be regulated by the beta -adrenergic signaling system in mouse embryos at such an early stage as 9.5 dpc.

AP and Iso. Couch et al. (6) reported developmental changes in AP of ventricular muscles of prenatal rats (10.5-20.5 dpc). However, the AP recorded from these rat hearts had limited magnitudes of both resting potential (positive to -50 mV in average) and Vmax (<25 V/s), suggesting that the tip of a Woodbury-Brady type of floating electrode may not be able to be impaled completely into the intracellular space of such immature and downsized ventricular muscle cells. AP of single ventricular myocytes recorded through a suction pipette electrode in the present study were comparable to those of myocytes in prenatal or neonatal rat hearts in terms of MDP, APA, and Vmax (7, 11). In addition, Iso significantly reduced the Vmax of AP (see Table 2). This is consistent with an inhibition of Na+-channel currents by Iso in adult mammalian ventricular myocytes, which has been linked to the Gs protein pathway (17, 20, 21). The fact that the slow diastolic depolarization was enhanced by Iso suggests the possible modulatory effect of Iso on pacemaker currents. Because the I-V curve shows that L-type Ca2+-channel currents at such negative potentials are almost inactive, other pacemaker currents may be involved in the response to Iso.

Stimulation of L-type Ca2+-channel currents by Iso. Our main finding in this report is that Iso, a beta -adrenergic agonist, enhanced IBa in 9.5-dpc mouse cardiomyocytes. The effect of Iso on IBa was mediated by beta -adrenergic receptors because of its reversible blockade by propranolol.

It has been well documented that beta -adrenergic agonists enhance L-type Ca2+-channel currents via Gs/AC signaling pathway in mature cardiomyocytes. In accordance, For also enhanced IBa in 9.5-dpc mouse cardiomyocytes, suggesting that a similar transducing mechanism may underlie the modulation of IBa by beta -adrenergic receptors at such an early stage.

The stimulatory effect of Iso on IBa was increased from 9.5-dpc to 18-dpc cardiomyocytes, reflecting some developmental changes in beta -adrenergic receptors or their transducing mechanism. Because the effect of For on IBa did not show significant increase from 9.5-dpc to 18-dpc cardiomyocytes, the signaling cascade downstream from the AC may develop before beta -adrenergic receptors.

Recently, several studies focused on age-related changes in beta -adrenergic modulation of Ca2+ channels. In the embryonic mouse heart, An et al. (1) reported that L-type Ca2+-channel currents of cardiomyocytes were enhanced by Iso (3 µM) at a late stage (17-20 dpc) but unaffected at an early stage (11-13 dpc). Masuda et al. (14) also observed in embryonic rat hearts that Iso had little effect at 15-18 dpc but caused a substantial increase in L-type Ca2+-channel currents at stages later than 20 dpc. The present results indicate a significant Iso-induced increase in L-type Ca2+-channel currents at an earlier stage of development (9.5 dpc) in the embryonic mouse heart.

Different experimental protocols might have contributed to such a discrepancy. One possibility is the difference in the temperatures used in experiments. Our experiments were conducted at 33°C, but Masuda et al. (14) used a lower temperature (22-25°C) and An et al. (1) did not mention the temperature used. The other possibility is the variance in the cell isolation procedures, especially those for enzymatic treatment. In any case, our findings are in agreement with the functionally effective beta -adrenergic receptors being expressed in 10.5- to 11.5-dpc rat embryos (8, 19).

In adult cardiomyocytes, the response of L-type Ca2+-channel currents to Iso is accompanied by a negative shift in the I-V relationship (15). In our data, however, Iso did not cause such a negative shift in the I-V relationship of IBa at 9.5 dpc. This is consistent with previous reports by An et al. (1) in 17- and 19-dpc embryonic mouse hearts and by Masuda et al. (14) in 20-dpc embryonic rat hearts. The key regulatory subunits of L-type Ca2+ channels expressed in embryonic hearts might be different from those expressed in adult hearts.

Our data may suggest that even in the 9.5-dpc embryonic mouse heart, both L-type Ca2+ channels and beta -adrenergic receptors are developed and that the activation of beta -adrenergic receptors enhances L-type Ca2+-channel currents, possibly via a cAMP-dependent pathway.

Physiological significance. In mature mammalian cardiomyocytes, excitation-contraction coupling is mediated mainly by Ca2+ release from the sarcoplasmic reticulum (SR), which is triggered by Ca2+ entry through sarcolemmal L-type Ca2+ channels (2, 9, 16). However, during early embryonic stages of development, cardiac contraction is more dependent on transsarcolemmal Ca2+ influx through Ca2+ channels because of immature Ca2+ regulatory properties of SR (3, 12). The expression of functional L-type Ca2+ channels in 9.5-dpc mouse embryos is in agreement with the fact that the primitive mouse heart begins to beat rhythmically at 9.0 dpc (10).

Pharmacological and biochemical experiments have indicated that the embryonic heart possesses beta -adrenergic receptors before the heart is innervated by the sympathetic division. Rat sympathetic innervation of the heart cannot be detected until gestation days 19-20 (12). Thus cardiac beta -adrenergic responses occur before sympathetic innervation, as indicated by our results and another previous paper (8). Norepinephrine was detected in 10.5-dpc fetal mice (23), and catecholamines were reported to be essential for early fetal mouse development (11.5 dpc) (23, 26). We propose that the embryonic heart should be under the control of humoral catecholamines even in the 9.5-dpc mouse.


    ACKNOWLEDGEMENTS

The authors thank Drs. Philip T. Palade (University of Texas Medical Branch at Galveston) and Noritsugu Tohse (Sapporo Medical University) for comments on the manuscript.


    FOOTNOTES

This study was supported by the grants from the Japanese Ministry of Science, Education, Sports and Culture (nos. 09770480 and 09877129).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests: K. Yasui, Dept. of Circulation, Div. of Regulation of Organ Function, Res. Inst. of Environmental Med., Nagoya Univ., Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.

Received 22 April 1998; accepted in final form 9 October 1998.


    REFERENCES
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References

1.   An, R. H., M. P. Davies, P. A. Doevendans, S. W. Kubalak, R. Bangalore, K. R. Chien, and R. S. Kass. Developmental changes in beta -adrenergic modulation of L-type Ca2+ channels in embryonic mouse heart. Circ. Res. 78: 371-378, 1996[Abstract/Free Full Text].

2.   Barcenas-Ruiz, L., and W. G. Wier. Voltage dependence of intracellular [Ca2+]i transients in guinea pig ventricular myocytes. Circ. Res. 61: 148-154, 1987[Abstract/Free Full Text].

3.   Boucek, R. J., Jr., M. E. Shelton, M. Artman, and E. Landon. Myocellular calcium regulation by the sarcolemmal membrane in the adult and immature rabbit heart. Basic Res. Cardiol. 80: 316-325, 1985[Medline].

4.   Chen, F.-C. M., H. I. Yamamura, and W. R. Roeske. Ontogeny of mammalian myocardial beta -adrenergic receptors. Eur. J. Pharmacol. 58: 255-264, 1979[Medline].

5.   Chen, F.-C. M., H. I. Yamamura, and W. R. Roeske. Adenylate cyclase and beta adrenergic receptor development in the mouse heart. J. Pharmacol. Exp. Ther. 222: 7-13, 1982[Abstract/Free Full Text].

6.   Couch, J. R., T. C. West, and H. E. Hoff. Development of the action potential of the prenatal rat heart. Circ. Res. 24: 19-31, 1969[Abstract/Free Full Text].

7.   Guo, W., K. Kamiya, J. Cheng, and J. Toyama. Changes in action potentials and ion currents in long-term cultured neonatal rat ventricular cells. Am. J. Physiol. 271 (Cell Physiol. 40): C93-C102, 1996[Abstract/Free Full Text].

8.   Hall, E. K. Acetylcholine and epinephrine effects on the embryonic rat heart. J. Cell. Comp. Physiol. 49: 187-200, 1957.

9.   Hatem, S. N., A. Bénardeau, C. Rücker-Martin, I. Marty, P. Chamisso, M. Villaz, and J.-J. Mercadier. Different compartments of sarcoplasmic reticulum participate in the excitation-contraction coupling process in human atrial myocytes. Circ. Res. 80: 345-353, 1997[Abstract/Free Full Text].

10.   Kaufman, M. H. (Editor). Assessment of development stage of pre- and postimplantation mouse embryos based on the staging system of Theiler (1989). In: The Atlas of Mouse Development. London, UK: Academic, 1995, p. 59Kaufman, M. H. (Editor). Assessment of development stage of pre- and postimplantation mouse embryos based on the staging system of Theiler (1989). In: The Atlas of Mouse Development. London, UK: Academic, 1995, p. 59.

11.   Kojima, M., H. Sada, and N. Sperelakis. Developmental changes in beta -adrenergic and cholinergic interactions on calcium-dependent slow action potentials in rat ventricular muscles. Br. J. Pharmacol. 99: 327-333, 1990[Medline].

12.   Kojima, M., N. Sperelakis, and H. Sada. Ontogenesis of transmembrane signaling systems for control of cardiac Ca2+ channels. J. Dev. Physiol. (Eynsham) 14: 181-219, 1990[Medline].

14.   Masuda, H., K. Sumii, and N. Sperelakis. Developmental changes in beta -adrenergic and muscarinic modulations of Ca2+ currents in fetal and neonatal ventricular cardiomyocytes of the rat. Reprod. Fertil. Dev. 8: 129-135, 1996[Medline].

15.   McDonald, T. F., S. Pelzer, W. Trautwein, and D. J. Pelzer. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol. Rev. 74: 365-507, 1994[Free Full Text].

16.   Näbauer, M., G. Callewaert, L. Cleemann, and M. Morad. Regulation of calcium release is gated by calcium current, not gating charge, in cardiac myocytes. Science 244: 800-803, 1989[Abstract/Free Full Text].

17.   Ono, K., T. Kiyosue, and M. Arita. Isoproterenol, DBcAMP, and forskolin inhibit cardiac sodium current. Am. J. Physiol. 256 (Cell Physiol. 25): C1131-C1137, 1989[Abstract/Free Full Text].

18.   Robkin, M., T. H. Shepard, and D. Baum. Autonomic drug effects on the heart rate of early rat embryos. Teratology 9: 35-44, 1974[Medline].

19.   Robkin, M. A., T. H. Shepard, and D. C. Dyer. Autonomic receptors of the early rat embryo heart: growth and development. Proc. Soc. Exp. Biol. Med. 151: 799-803, 1976[Medline].

20.   Schubert, B., A. M. J. VanDongen, G. E. Kirsch, and A. M. Brown. beta -Adrenergic inhibition of cardiac sodium channels by dual G-protein pathways. Science 245: 516-519, 1989[Abstract/Free Full Text].

21.   Schubert, B., A. M. J. VanDongen, G. E. Kirsch, and A. M. Brown. Inhibition of cardiac Na+ currents by isoproterenol. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H977-H982, 1990[Abstract/Free Full Text].

22.   Slotkin, T. A., C. Lau, and F. J. Seidler. beta -Adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins. Toxicol. Appl. Pharmacol. 129: 223-234, 1994[Medline].

23.   Thomas, S. A., A. M. Matsumoto, and R. D. Palmiter. Noradrenaline is essential for mouse fetal development. Nature 374: 643-646, 1995[Medline].

24.   Yatani, A., and A. M. Brown. Rapid beta -adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway. Science 245: 71-74, 1989[Abstract/Free Full Text].

25.   Yatani, A., J. Codina, Y. Imoto, J. P. Reeves, L. Birnbaumer, and A. M. Brown. A G protein directly regulates mammalian cardiac calcium channels. Science 238: 1288-1292, 1987[Abstract/Free Full Text].

26.   Zhou, Q.-Y., C. J. Quaife, and R. D. Palmiter. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374: 640-643, 1995[Medline].


Am J Physiol Heart Circ Physiol 276(2):H608-H613
0002-9513/99 $5.00 Copyright © 1999 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Niwa, K. Yasui, T. Opthof, H. Takemura, A. Shimizu, M. Horiba, J.-K. Lee, H. Honjo, K. Kamiya, and I. Kodama
Cav3.2 subunit underlies the functional T-type Ca2+ channel in murine hearts during the embryonic period
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2257 - H2263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Banach, M. D. Halbach, P. Hu, J. Hescheler, and U. Egert
Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2114 - H2123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. A. Porter Jr. and S. A. Rivkees
Ontogeny of humoral heart rate regulation in the embryonic mouse
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R401 - R407.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Yasui, W. Liu, T. Opthof, K. Kada, J.-K. Lee, K. Kamiya, and I. Kodama
If Current and Spontaneous Activity in Mouse Embryonic Ventricular Myocytes
Circ. Res., March 16, 2001; 88(5): 536 - 542.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, W.
Right arrow Articles by Toyama, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, W.
Right arrow Articles by Toyama, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online